Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2012 3
2013 3
2014 10
2015 8
2016 11
2017 10
2018 6
2019 14
2020 15
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year
Filters applied: . Clear all
Page 1
Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges.
Rijavec E, Coco S, Genova C, Rossi G, Longo L, Grossi F. Rijavec E, et al. Cancers (Basel). 2019 Dec 19;12(1):17. doi: 10.3390/cancers12010017. Cancers (Basel). 2019. PMID: 31861557 Free PMC article. Review.
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine.
Tagliamento M, Rijavec E, Barletta G, Biello F, Rossi G, Grossi F, Genova C. Tagliamento M, et al. Among authors: rijavec e. Expert Opin Biol Ther. 2018 Jul;18(7):829-835. doi: 10.1080/14712598.2018.1492539. Epub 2018 Jul 4. Expert Opin Biol Ther. 2018. PMID: 29936901 Review.
Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers.
Pagni F, Guerini-Rocco E, Schultheis AM, Grazia G, Rijavec E, Ghidini M, Lopez G, Venetis K, Croci GA, Malapelle U, Fusco N. Pagni F, et al. Among authors: rijavec e. Int J Mol Sci. 2019 Nov 1;20(21):5452. doi: 10.3390/ijms20215452. Int J Mol Sci. 2019. PMID: 31683784 Free PMC article. Review.
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer.
Tagliamento M, Genova C, Rijavec E, Rossi G, Biello F, Dal Bello MG, Alama A, Coco S, Boccardo S, Grossi F. Tagliamento M, et al. Among authors: rijavec e. Expert Opin Pharmacother. 2018 Dec;19(18):2055-2062. doi: 10.1080/14656566.2018.1540591. Epub 2018 Nov 3. Expert Opin Pharmacother. 2018. PMID: 30392436 Review.
Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab.
Genova C, Boccardo S, Mora M, Rijavec E, Biello F, Rossi G, Tagliamento M, Dal Bello MG, Coco S, Alama A, Vanni I, Barletta G, Bianchi R, Maggioni C, Bruzzi P, Grossi F. Genova C, et al. Among authors: rijavec e. J Clin Med. 2019 Oct 1;8(10):1566. doi: 10.3390/jcm8101566. J Clin Med. 2019. PMID: 31581482 Free PMC article.
Comparison Between 18F-FDG PET-Based and CT-Based Criteria in Non-Small Cell Lung Cancer Patients Treated with Nivolumab.
Rossi G, Bauckneht M, Genova C, Rijavec E, Biello F, Mennella S, Dal Bello MG, Cittadini G, Bruzzi P, Piva R, Ceriani V, Sambuceti G, Lopci E, Morbelli S, Grossi F. Rossi G, et al. Among authors: rijavec e. J Nucl Med. 2020 Jul;61(7):990-998. doi: 10.2967/jnumed.119.233056. Epub 2019 Dec 5. J Nucl Med. 2020. PMID: 31806768
Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds.
Tagliamento M, Genova C, Rossi G, Coco S, Rijavec E, Dal Bello MG, Boccardo S, Grossi F, Alama A. Tagliamento M, et al. Among authors: rijavec e. Expert Opin Investig Drugs. 2019 Jun;28(6):513-523. doi: 10.1080/13543784.2019.1627326. Epub 2019 Jun 7. Expert Opin Investig Drugs. 2019. PMID: 31159588 Review.
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients.
Sarocchi M, Grossi F, Arboscello E, Bellodi A, Genova C, Dal Bello MG, Rijavec E, Barletta G, Rossi G, Biello F, Ghigliotti G, Canepa M, Mussap M, Brunelli C, Spallarossa P. Sarocchi M, et al. Among authors: rijavec e. Oncologist. 2018 Aug;23(8):936-942. doi: 10.1634/theoncologist.2017-0452. Epub 2018 Mar 22. Oncologist. 2018. PMID: 29567824 Free PMC article.
Advances in treatment of mesothelioma.
Maggioni C, Barletta G, Rijavec E, Biello F, Gualco E, Grossi F. Maggioni C, et al. Among authors: rijavec e. Expert Opin Pharmacother. 2016 Jun;17(9):1197-205. doi: 10.1080/14656566.2016.1176145. Epub 2016 Apr 21. Expert Opin Pharmacother. 2016. PMID: 27055148 Review.
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial.
Santo A, Pilotto S, Galetta D, Grossi F, Fasola G, Romano G, Bonanno L, Bearz A, Papi M, Roca E, Catino A, Follador A, Rijavec E, Genova C, Petrillo P, Favaretto A, Giannone L, Milella M, Tortora G, Giannarelli D, Bria E; Italian association FONICAP (Operative National Interdisciplinary Force against Lung Cancer). Santo A, et al. Among authors: rijavec e. Lung Cancer. 2019 Aug;134:121-126. doi: 10.1016/j.lungcan.2019.06.011. Epub 2019 Jun 11. Lung Cancer. 2019. PMID: 31319970 Clinical Trial.
73 results
Jump to page
Feedback